hafnium has been researched along with Oropharyngeal Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernois, K; Borcoman, E; Calugaru, V; Calvo, E; Chilles, A; Dimitriu, M; Doger, B; Fakhry, N; Hee Kam, SW; Hoffmann, C; Jouffroy, T; Le Tourneau, C; Liem, X; Mirabel, X; Moreno, V; Rodriguez, J; Salas, S | 1 |
1 trial(s) available for hafnium and Oropharyngeal Neoplasms
| Article | Year |
|---|---|
Phase I dose-escalation study of NBTXR3 activated by intensity-modulated radiation therapy in elderly patients with locally advanced squamous cell carcinoma of the oral cavity or oropharynx.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Follow-Up Studies; Hafnium; Humans; Male; Maximum Tolerated Dose; Nanoparticles; Non-Randomized Controlled Trials as Topic; Oropharyngeal Neoplasms; Oxides; Prognosis; Radiotherapy, Intensity-Modulated | 2021 |